Some NY Lawmakers Say Illicit Pot Shops Must Close Before Adding Licensed Shops
After officially legalizing cannabis for adult use in New York, the journey that followed has been fairly tumultuous as multiple roadblocks have delayed shop licensure and hindered the legal industry’s full potential. A number of lawsuits and a change in gubernatorial leadership delayed dispensary licensure and openings, in turn allowing the illicit market to flourish…
You might be interested in
Study: ADHD Patient MMJ Use Leads to Improvements in Anxiety, Sleep, Quality of Life
When it comes to medical benefits, cannabis is often associated with its anti-inflammatory, pain-relieving and sedative properties. But given the versatile nature of the plant, researchers are looking beyond some of the more common qualifying medical conditions to uncover the full medicinal potential of cannabis. Though it’s largely under-researched, it’s possible that cannabis could work…
You might be interested in
Study Finds Medical Cannabis Provides Lasting Benefits for Osteoarthritis Patients
Patients with osteoarthritis reported a reduction in pain associated with the disease when using medical cannabis, according to the results of a recently published study by British researchers. Osteoarthritis (OA) is a degenerative disease of the joints characterized by the wearing down of cartilage at the ends of bones. The condition is the most common…
You might be interested in
Alaska House Approves Bill To Establish Task Force To Investigate Psychedelic Therapy
On May 2, the Alaska House of Representatives recently approved House Bill 228 in a 36-4 vote, which would establish a task force to regulate various psychedelic-assisted therapies. The official name of the group will be Alaska Task Force for the Regulation of Psychedelic Medicines Approved by the United States Food and Drug Administration. Passing…
You might be interested in
Psychedelic Pioneer Peggy Mellon Hitchcock Dies at 90
Margaret “Peggy” Mellon Hitchcock, an ultra-wealthy heiress who grew up in the Andrew Mellon estate and its fortunes, funded LSD-fueled adventures for Dr. Timothy Leary and Dr. Richard “Ram Dass” Alpert, passed away on April 9 and an elaborate obituary was written by Penelope Green for the New York Times on May 3. “Pretty Peggy…
You might be interested in
Enemies of Weed Legalization Are Already Raising Money To Challenge Federal Rescheduling Effort
Last week, the Drug Enforcement Administration (DEA) shared that marijuana would be rescheduled from a Schedule I, meaning that the plant was classified as a substance with no accepted medical value, such as heroin, to a Schedule III, controlled substances that allow for some medical use, such as ketamine. While cannabis advocates, stoners, and anyone…
You might be interested in
Where the Sherbwalk Ends
A fruity yet spicy rendition of Permanent Marker from Pleasant Effects is boosting the profile of the Rhode Island-based grower across the East Coast, as is its eye-catching and artistic packaging including a nostalgic take on a Shel Silverstein classic. Sam, one of the co-founders behind the brand, gained non-cannabis know-how at a local hydroponics…
You might be interested in
Is Hop Latent Viroid Everywhere?
Hop latent viroid (HLVd) is one of the most devastating things ever to hit cannabis, with researchers estimating it could be costing the industry up to $4 billion per year in financial loss. But are the streets safer than the recreational mega-farms that were decimated in the transition to legalization? We reached out to some…
You might be interested in
Connecticut House Approve Bill Regulating Hemp Products
The Connecticut House of Representatives this week passed a bill to regulate ingestible hemp products, with lawmakers saying the legislation is necessary to protect the public from the potentially harmful effects of hemp-derived cannabinoids. The House approved the measure, House Bill 5150, by a vote of 130-16 on Tuesday, less than three months after it…
You might be interested in
Clinical Trial To Assess LSD Microdosing For PMS
MindBio Therapeutics Corp. said that “MB22001, a proprietary and self-titratable form of Lysergic Acid Diethylamide (LSD) designed for safe take home microdosing” has been approved for take-home use in a pair of clinical trials. “The trials in women’s health aim to address a huge unmet need in effectively treating Pre-Menstrual Syndrome (PMS) and Pre-Menstrual Dysphoric…
You might be interested in